Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited state that they take no responsibility for the contents of the announcement, make no representation as to its accuracy or completeness, and expressly disclaim any liability for loss arising from or in reliance upon its contents.

Shanghai Pharmaceuticals Holding Co., Ltd. (Stock Code: 02607) released a notice dated 17 October 2025. According to the announcement, the board of directors will convene a meeting on Thursday, 30 October 2025. The main purposes include reviewing and approving the company’s third quarterly results for the nine months ended 30 September 2025, authorizing the publication of the results, and considering the possible payment of an interim dividend.

The announcement also confirms that the board of directors currently comprises Executive Directors Mr. YANG Qiuhua (Chairman), Mr. SHEN Bo, Mr. LI Yongzhong, and Mr. DONG Ming; Non-executive Director Mr. ZHANG Wenxue; and Independent Non-executive Directors Mr. GU Zhaoyang, Mr. Manson FOK, Mr. WANG Zhong, and Ms. MAN Kwan.